Shenzhen Ionova Life Sciences Co., Ltd.
Clinical trials sponsored by Shenzhen Ionova Life Sciences Co., Ltd., explained in plain language.
-
New hope for Hard-to-Treat prostate cancer: experimental drug INV-9956 enters human trials
Disease control Recruiting nowThis study tests an experimental drug called INV-9956 in men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. The goal is to find a safe dose and see if the drug can shrink tumors or slow the disease. About 84 adult men will take p…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 12:13 UTC
-
New drug combo aims to tame advanced cancers in early trial
Disease control Recruiting nowThis study is for adults with advanced solid tumors that have stopped responding to standard treatments. It tests an experimental drug called INV-1120, given alone or together with the immunotherapy pembrolizumab. The main goals are to find the safest dose and to watch for side e…
Phase: PHASE1 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC